search
Back to results

Acupuncture for Vulvodynia: A Pre-pilot Study

Primary Purpose

Vulvodynia, Vulvar Vestibulitis, Dyspareunia

Status
Completed
Phase
Not Applicable
Locations
United States
Study Type
Interventional
Intervention
Active Acupuncture
Placebo Acupuncture
Sponsored by
University of Illinois at Chicago
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional basic science trial for Vulvodynia

Eligibility Criteria

18 Years - 45 Years (Adult)FemaleDoes not accept healthy volunteers

Inclusion Criteria:

  • women previously diagnosed with generalized vulvodynia
  • women previously diagnosed with localized vestibulodynia,

Exclusion Criteria:

  • pregnancy
  • menopause
  • interstitial cystitis
  • irritable bowel syndrome
  • untreated vaginitis
  • cervicitis
  • pelvic inflammatory disease
  • any other pelvic pathology causing pain
  • concomitant physical therapy
  • concomitant biofeedback
  • concomitant massage
  • additional acupuncture

Sites / Locations

  • A Center for Oriental Medicine

Arms of the Study

Arm 1

Arm 2

Arm Type

Experimental

Placebo Comparator

Arm Label

Active Acupuncture

Placebo

Arm Description

Active Acupuncture 2 times per week for 5 weeks

Placebo Acupuncture 2 times per week for 5 weeks

Outcomes

Primary Outcome Measures

Change in Vulvar Pain Scale
PainReportIt, the computerized McGill Pain Questionnaire
Change in Dyspareunia Questionnaire
Female Sexual Function Index

Secondary Outcome Measures

Vulvar Function Status Questionnaire
Assesses vulvar function

Full Information

First Posted
November 30, 2015
Last Updated
June 12, 2017
Sponsor
University of Illinois at Chicago
search

1. Study Identification

Unique Protocol Identification Number
NCT02704234
Brief Title
Acupuncture for Vulvodynia: A Pre-pilot Study
Official Title
Acupuncture for Vulvodynia: A Double-blinded Feasibility Pre-pilot Study
Study Type
Interventional

2. Study Status

Record Verification Date
June 2017
Overall Recruitment Status
Completed
Study Start Date
November 2015 (undefined)
Primary Completion Date
May 2016 (Actual)
Study Completion Date
May 2016 (Actual)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Principal Investigator
Name of the Sponsor
University of Illinois at Chicago

4. Oversight

Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No
Data Monitoring Committee
Yes

5. Study Description

Brief Summary
Vulvodynia is a women's pain condition. Women have pain in their vulva, the area in their genitals between the vagina and labia (lips of the vagina). They also have pain when they have sexual intercourse or insert anything in the vagina. Sometimes they have so much pain, that they cannot have sex. This research is being done for two reasons. The first reason is to test a set of special needles called double-blinded acupuncture needles to give acupuncture treatments (one is a real needle and the other is a fake needle). The second reason is to develop a protocol (checklist) that will be used in this and future studies, and to identify and resolve any procedural problems. The protocol will be first tested by the principal investigator who is also an acupuncturist. The investigator will perform acupuncture using the protocol, if necessary change the protocol, and then teach a second acupuncturist using the modified protocol how to use the double-blinded acupuncture needles. The real needle called the penetrating needle penetrates the skin. The fake needle called the non-penetrating placebo touch needle does not penetrate the skin but it touches the skin so it feels like a needle is being inserted. It has a blunt tip. Participants can't see which needle they are getting acupuncture with because the needles are housed in a double-blinded needle device which has two tubes (an inner and an outer) that neither the acupuncturists nor the participants can see through. If a fake acupuncture needle can be used in acupuncture research like a sugar pill is used for drug studies to see how well the real medicine works, the investigators can see how effective acupuncture is. The investigators will be testing these needles to treat participants with vulvodynia.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Vulvodynia, Vulvar Vestibulitis, Dyspareunia, Pain

7. Study Design

Primary Purpose
Basic Science
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Masking
ParticipantCare ProviderInvestigatorOutcomes Assessor
Allocation
Randomized
Enrollment
6 (Actual)

8. Arms, Groups, and Interventions

Arm Title
Active Acupuncture
Arm Type
Experimental
Arm Description
Active Acupuncture 2 times per week for 5 weeks
Arm Title
Placebo
Arm Type
Placebo Comparator
Arm Description
Placebo Acupuncture 2 times per week for 5 weeks
Intervention Type
Other
Intervention Name(s)
Active Acupuncture
Other Intervention Name(s)
Penetrating Acupuncture Needle
Intervention Description
Active Acupuncture two times per week for 5 weeks
Intervention Type
Other
Intervention Name(s)
Placebo Acupuncture
Intervention Description
Placebo Acupuncture two times per week for 5 weeks
Primary Outcome Measure Information:
Title
Change in Vulvar Pain Scale
Description
PainReportIt, the computerized McGill Pain Questionnaire
Time Frame
baseline and twice weekly for 5 weeks
Title
Change in Dyspareunia Questionnaire
Description
Female Sexual Function Index
Time Frame
baseline and once per week for 5 weeks
Secondary Outcome Measure Information:
Title
Vulvar Function Status Questionnaire
Description
Assesses vulvar function
Time Frame
at baseline and 5 weeks
Other Pre-specified Outcome Measures:
Title
Sleep Quality Scale
Description
Pittsburgh Sleep Quality Index
Time Frame
at baseline and 5 weeks
Title
The Protocol Acceptability Scale for Treating Vulvodynia with Acupuncture
Description
Acceptability of the acupuncture protocol for the participant
Time Frame
5 weeks
Title
Double-Blinded Needle Questionnaires for the Acupuncturist and for the Participant
Description
Assesses the Ability of the Acupuncturist and Subject to Remain Blind
Time Frame
5 weeks

10. Eligibility

Sex
Female
Minimum Age & Unit of Time
18 Years
Maximum Age & Unit of Time
45 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria: women previously diagnosed with generalized vulvodynia women previously diagnosed with localized vestibulodynia, Exclusion Criteria: pregnancy menopause interstitial cystitis irritable bowel syndrome untreated vaginitis cervicitis pelvic inflammatory disease any other pelvic pathology causing pain concomitant physical therapy concomitant biofeedback concomitant massage additional acupuncture
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
judith schlaeger, PhD
Organizational Affiliation
University of Illinois at Chicago
Official's Role
Principal Investigator
Facility Information:
Facility Name
A Center for Oriental Medicine
City
Wilmette
State/Province
Illinois
ZIP/Postal Code
60098
Country
United States

12. IPD Sharing Statement

Plan to Share IPD
No
Citations:
PubMed Identifier
29686883
Citation
Schlaeger JM, Takakura N, Yajima H, Takayama M, Steffen AD, Gabzdyl EM, Nisi RA, McGowan Gruber K, Bussell JM, Wilkie DJ. Double-blind acupuncture needles: a multi-needle, multi-session randomized feasibility study. Pilot Feasibility Stud. 2018 Apr 13;4:72. doi: 10.1186/s40814-018-0265-9. eCollection 2018.
Results Reference
derived

Learn more about this trial

Acupuncture for Vulvodynia: A Pre-pilot Study

We'll reach out to this number within 24 hrs